A novel approach to developing different malaria prevention measures is seeing progress
Register for full access
Our library content is no longer freely available. Please register to gain access to more than 12,000 innovations, updated daily. Our content is global in scope and covers solutions to the world's biggest challenges across 18 sectors.
Spotted: Malaria is a leading cause of illness and death and puts huge pressure on strained health systems – in some countries with a high malaria burden, it can account for up to 40 per cent of public health expenditure. One of the organisations working to fight malaria is Landcent Group, which has developed a novel programme to identify new insecticides.
Landcent’s Active Ingredient Discovery Platform investigates natural and indigenous knowledge bases to identify active ingredients for development into biopesticides. Using this platform, the company has screened more than 200,000 natural compounds in just two years.
The company’s portfolio of solutions includes: Long-Lasting Insecticidal Nets (LLINs); Indoor Residual Sprays (IRS); chewable anti-malarial pills, which have been developed with a unique flavour to make them more appealing for children; and long-lasting topical repellents.
Since its founding in 2011, Landcent has secured grants from the Bill and Melinda Gates Foundation and investments from Shan Xiangshuang, of Hone Capital — one of Silicon Valley’s biggest funds.
In 2021, malaria caused an estimated 247 million clinical episodes, and 619,000 deaths. Innovators have responded with various advances. In the archive, Springwise has spotted the use of a smartphone to diagnose the disease and drones that map mosquito breeding grounds.
Written By: Lisa Magloff